References
- Talaulikar D, Choudhury A, Shadbolt B, Brwon M. Lymphocytopenia as a prognostic marker for diffuse large B cell lymphoma. Leuk Lymphoma 2008; 49: 959–964
- Sehn L H. (2000) Optimal use of prognostic factors in non-Hodgkin lymphoma. Hematology, Education Program Book. The American Society of Hematology 48th Annual Meeting, Atlanta, December, 2006. American Society of hematology, Washington, DC, 295–302
- Kim D H, Baek J H, Chae Y S, Kim Y K, Kim H J, Park Y H, et al. Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma. Leukemia 2007; 21: 2227–2230
- Porrata L F, Markovic S N. Timely reconstitution of immune competence affect clinical outcome following autologous stem cell transplantation. Clin Exp Med 2004; 4: 78–85
- Behl D, Porrata L F, Markovic S N, Letendre L, Pruthi R K, Hook C C, et al. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia 2006; 20: 29–34
- De Angulo G, Hernandez M, Morales-Arias J, Herzog C E, Anderson P, Wolff J, et al. Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma. J Pediatr Hematol/Oncol 2007; 29: 48–52
- De Angulo G, Yuen C, Palla S L, Anderson P M, Zweidler-Mckay P A. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implication for risk stratification and future studies. Cancer 2008; 112: 407–415
- Plonquet A, Haioun C, Jais J P, Debard A L, Salles G, Bene M C, et al. Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma. Ann Oncol 2007; 18: 1209–1215